Advanced Search
YANG Lei, NI Run-zhou, XIAO Ming-bing, LI Feng, LU Cui-hua, HUA Guo-ping. The Value of HS-AFP for Judgement of Severity and Post-TACE Prognosis in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 514-517. DOI: 10.3971/j.issn.1000-8578.2238
Citation: YANG Lei, NI Run-zhou, XIAO Ming-bing, LI Feng, LU Cui-hua, HUA Guo-ping. The Value of HS-AFP for Judgement of Severity and Post-TACE Prognosis in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 514-517. DOI: 10.3971/j.issn.1000-8578.2238
shu

The Value of HS-AFP for Judgement of Severity and Post-TACE Prognosis in Hepatocellular Carcinoma

  • Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong 226001, China ( *Present : Nantong Tumor Hospital, Nantong 226361)

More Information
  • Received Date: May 24, 2006
  • Revised Date: November 13, 2006
    Graphical Abstract
    • Abstract
  • Objective 　To investigate the clinical value of hepatoma-specific alpha-fetoprotein ( HS-AFP) for judgment of severity, treatment response and prognosis in patients with hepatocellular carcinoma ( HCC) undergoing transcatheter arterial chemoembolization. ( TACE) . Methods 　HS-AFP was separated with PAGE and determined with Western blot . HS-AFP was measured in 41 cases with HCC before and af ter TACE. The correlations were analyzed between HS-AFP and tumor size, stage, response to treatment as well as survival time. Results 　The positive rate of HS-AFP was higher in HCC cases with tumor sizes larger than 5 cm than those with tumor size less than 5 cm, and higher in the cases at stage Ⅱ a + b than those at stage Ⅰ. The response rate to TACE was lower in cases with positive HS-AFP than those with negative HS-AFP af ter operation (4. 5 % vs. 73. 6 %, P < 0. 001) . Both univariate and multivariate analysis revealed that HS-AFP af ter TACE was related to the prognosis. Conclusion 　HS-AFP is useful to judgment of severity of HCC before TACE. Particularly, it is valuable for judgment of prognosis after TACE.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
    [2]Wang Yuxiang, Wang Jun, Zhu Shuchai, Tian Dandan, Lv Dongjie, Wang Yi, Qiao Xueying. Comparison of Prognosis on Esopageal Carcinoma Treated with 3D-CRT and IMRT for Elderly Patients[J]. Cancer Research on Prevention and Treatment, 2012, 39(08): 1008-1013. DOI: 10.3971/j.issn.1000-8578.2012.08.031
    [3]Sun Jun, Zhang Qiang, Zhu Chen, Zhang Leilei, Ma Jiaming. Observation of Short-term Efficacy of Intensity-modulated Radiotherapy for Middle Thoracic Esophageal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 318-320. DOI: 10.3971/j.issn.1000-8578.2012.03.018
    [4]WANG Yu-xiang, ZHU Shu-chai, QIU Rong, SU Jing-wei, SHEN Wen-bin. Prognosis of T4 Esophageal Carcinoma with Three-dimensional Conformal Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2011, 38(06): 690-694. DOI: 10.3971/j.issn.1000-8578.2011.06.023
    [5]WANG Jing, QIAO Xue-ying, JIA Jing-hao, LIU Xin, HUO Jun-jie, SONG Yu-zhi, GAO Xian-shu. Prognosis of Three Dimensional Conformal Radiotherapy of Locally Advanced Non-small Cell Lung Cancer with Involved-field[J]. Cancer Research on Prevention and Treatment, 2011, 38(02): 195-198. DOI: 10.3971/j.issn.1000-8578.2011.02.020
    [6]WANG Ren-sheng, WEI Bo, HUANG Su-ning, RUAN Chang-li. Clinical Observation of 128 Nasopharyngeal Carcinoma Patients for Intensity Modulated Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2010, 37(05): 570-574. DOI: 10.3971/j.issn.1000-8578.2010.05.022
    [7]WEI Rui, ZHANG Yang-de, HE Jian-tai, DAI You-yi. Postoperative Intensity Modulated Radiation Therapy for 30 Cases with Malignant Gliomas[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 453-456. DOI: 10.3971/j.issn.1000-8578.2010.04.023
    [8]ZHANG Hong-bo, CHEN Long-hua, WU De-hua, CAO Xiao-fei. Therapeutic Effects Evaluation of Three-dimensional Conformal Radiotherapy for Stage Ⅰ Primary Hepatocellular Carcinoma and Multi-factors Analysis of the Prognosis[J]. Cancer Research on Prevention and Treatment, 2007, 34(05): 378-381. DOI: 10.3971/j.issn.1000-8578.1674
    [9]HE Han-ping, GUO You-quan, HU Xin-chuan, XU Li-ming, WU Jian-ping. Three Dimension Radiotherapy of Lung Cancer with Brain Metastasis[J]. Cancer Research on Prevention and Treatment, 2006, 33(11): 831-833. DOI: 10.3971/j.issn.1000-8578.368
    [10]HE Xia, ZHAI Zhen-yu, JI Hong, ZHANG Yi-qin. The Short-term Clinical Observation of IMRT in First-treated Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(04): 272-274. DOI: 10.3971/j.issn.1000-8578.3378

Catalog

    Get Citation
    PDF
    XML
    Article views (2118) PDF downloads (597) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：11620806 Visits today：28566

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return